OLDAKER & WILLISON, LLP for JUUL LABS, INC.
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
H.R. 7610/S.___, Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act, FY 2021; provisions related to the regulation of tobacco and electronic nicotine delivery system products, including implementation of a national track and trace system to ensure enforcement against illicit trade; H.R. ____/S____,Labor,Health and Human Services, and Related Agencies Appropriations Act, FY2021; discussions related to the correlation between vitamin E acetate and the EVALI cases. S. 2517, Tobacco Tax Equity Act of 2019; S. 2519, Prohibiting Non-tobacco E-cigarette Flavors; S. 2536, E-Cigarette Device Standards Act of 2019
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANDREW B. WILLISON | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.